IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $44,000 | -68.6% | 10,400 | -67.2% | 0.00% | 0.0% |
| Q4 2021 | $140,000 | -64.8% | 31,700 | +166.9% | 0.00% | -76.9% |
| Q3 2021 | $398,000 | -83.9% | 11,877 | -89.0% | 0.01% | -94.1% |
| Q1 2019 | $2,476,000 | +25.1% | 108,408 | -14.5% | 0.22% | +76.8% |
| Q4 2018 | $1,980,000 | +49400.0% | 126,814 | +786.8% | 0.12% | – |
| Q1 2018 | $4,000 | -33.3% | 14,300 | +12.6% | 0.00% | – |
| Q4 2017 | $6,000 | -60.0% | 12,700 | +5.0% | 0.00% | -100.0% |
| Q2 2017 | $15,000 | -89.9% | 12,100 | -68.1% | 0.00% | -88.9% |
| Q1 2017 | $149,000 | +77.4% | 37,900 | +196.1% | 0.01% | +125.0% |
| Q4 2016 | $84,000 | +33.3% | 12,800 | -61.8% | 0.00% | +100.0% |
| Q3 2016 | $63,000 | +600.0% | 33,500 | +196.5% | 0.00% | +100.0% |
| Q2 2016 | $9,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |